T-1840383 is a potent ATP-competitive inhibitor of c-Met and VEGFR-2, with IC50 values of 1.9 nM, 7.7 nM, 2.2 nM, and 5.5 nM against c-Met, VEGFR1/Flt-1, VEGFR2/KDR/Flk-1, and VEGFR3/Flt-4, respectively; it is used for targeting angiogenesis and tumor growth by inhibiting these receptor tyrosine kinases.